FDA AmVaz Review Could Take Two Months
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA's re-evaluation of the review for Dr. Reddy's AmVaz (amlodipine maleate) should be completed within two months, the agency says in a Feb. 18 court filing